Z. Tomasevic
Impact in
-
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Gϋnter von Minckwitz (2 shared papers)Nan Zhang (1 shared paper)Patrícia Xavier Santi (2 shared papers)Serafín Morales (1 shared paper)Marco Colleoni (2 shared papers)Hans‐Christian Kolberg (2 shared papers)Vladimir Hanes (3 shared papers)Marko Radulović (2 shared papers)
- Journals
- The International Journal of Biological Markers (3 papers)The Oncologist (2 papers)Journal of Clinical Oncology (2 papers)Microscopy and Microanalysis (1 paper)Familial Cancer (1 paper)
- Partner nations
- SerbiaUnited StatesCroatia
In The Last Decade
Z. Tomasevic
22 papers receiving 300 citations
Peers
Comparison fields: 5 of 75
- Oncology 150
- Internal Medicine 15
- Radiology, Nuclear Medicine and Imaging 89
- Immunology 70
- Cancer Research 42
Countries citing papers authored by Z. Tomasevic
This map shows the geographic impact of Z. Tomasevic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Tomasevic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Tomasevic more than expected).
Fields of papers citing papers by Z. Tomasevic
This network shows the impact of papers produced by Z. Tomasevic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Tomasevic. The network helps show where Z. Tomasevic may publish in the future.
Co-authors
The 25 scholars most cited alongside Z. Tomasevic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 84 | |
| 2 | 2015 | 41 | |
| 3 | 2016 | 35 | |
| 4 | 2015 | 26 | |
| 5 | 2018 | 25 | |
| 6 | 2019 | 14 | |
| 7 | 2013 | 14 | |
| 8 | 2016 | 14 | |
| 9 | 2015 | 12 | |
| 10 | Oral administration of antineoplastic agents: the challenges for healthcare professionals. | 2015 | 12 |
| 11 | 2013 | 9 | |
| 12 | 2017 | 3 | |
| 13 | [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults]. | 1996 | 3 |
| 14 | 2009 | 2 | |
| 15 | 2003 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2003 | 2 | |
| 19 | 2012 | 1 | |
| 20 | 2019 | 1 |
About Z. Tomasevic
Z. Tomasevic is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 24 papers that have together received 306 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), BRCA gene mutations in cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (150 citations), Internal Medicine (15 citations), Radiology, Nuclear Medicine and Imaging (89 citations), Immunology (70 citations) and Cancer Research (42 citations). Z. Tomasevic has collaborated with scholars based in Serbia, United States and Croatia. Frequent co-authors include Gϋnter von Minckwitz, Nan Zhang, Patrícia Xavier Santi, Serafín Morales, Marco Colleoni, Hans‐Christian Kolberg, Vladimir Hanes, Marko Radulović, Ksenija Kanjer and Zorka Milovanović. Their work appears in journals such as The International Journal of Biological Markers, The Oncologist, Journal of Clinical Oncology, Microscopy and Microanalysis and Familial Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.